Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microtubule binding region (MBR) of tau protein is a critical domain responsible for the interaction between tau and microtubules, essential for maintaining neuronal structure and function. It consists of three or four tandemly repeated sequences (R1–R4) and a pseudorepeat region (PRR). This region binds tubulin subunits and stabilizes assembled microtubules in axons, supporting neuronal morphology and intracellular transport. Post-translational modifications, such as phosphorylation and acetylation, regulate its binding affinity. Disruptions to this region's function lead to tau detachment, aggregation, and neurofibrillary tangle formation, characteristic of Alzheimer's disease and other tauopathies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule Binding Region of Tau Protein (MBR of Tau).